Compact Imaging, Novartis collaborate to develop home retinal monitoring system

Compact Imaging has signed a collaboration agreement with Novartis Pharma to develop a home-based monitor to detect progression of age-related macular degeneration and diabetic retinopathy, according to a press release.

Using Compact Imaging’s MRO (Multiple Reference OCT) technology, the home retinal monitoring device is expected to provide a simple and affordable way for patients to monitor themselves and for information to be transferred via the cloud to physicians, the release said.

“Home monitoring and rapid reporting of results to treating physicians has the potential to dramatically transform this burdensome patient care model,” Compact Imaging CEO Don Bogue said in the release. “Most importantly, it will help patients around the world get the full benefit of today’s sight-saving therapies.”

Novartis is funding the development of the monitor. Compact Imaging expects clinical trials of a prototype system to begin next year.

Read more:

Source: Healio